Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

INTRODUCTION: Gout affects 2.5% of the UK's adult population and is now the most common type of inflammatory arthritis. The long-term management of gout requires reduction of serum urate levels and this is most often achieved with use of xanthine oxidase inhibitors, such as allopurinol. Febuxos...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: MacDonald, Thomas M, Ford, Ian, Nuki, George, Mackenzie, Isla S, De Caterina, Raffaele, Findlay, Evelyn, Hallas, Jesper, Hawkey, Christopher J, Ralston, Stuart, Walters, Matthew, Webster, John, McMurray, John, Perez Ruiz, Fernando, Jennings, Claudine G
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Publishing Group 2014
الموضوعات:
Research Methods
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120410/
https://ncbi.nlm.nih.gov/pubmed/25011991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005354
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة